Single answer
Is Artivion Inc (AORT) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Artivion Inc is $52.00, which is $16.04 (44.61%) above the current price today's price.
Low target: $50.00 | High target: $55.00
Latest analyst updates
Recent rating and price target changes for this stock.
Company snapshot
A quick overview of the business and its public profile.
Artivion Inc manufactures processes and distributes medical devices and implantable human tissues worldwide The company offers BioGlue a polymer consisting of bovine blood protein and an agent for crosslinking proteins for cardiac vascular neurologic and pulmonary procedures cardiac preservation services PhotoFix a bovine pericardial patch and Evita Open Plus and Evita Open Neo It also provides Extra design engineering systems for the treatment of aortic vascular diseases Enside an offtheshelf stent graft for the treatment of thoracoabdominal disease Evita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms Enya a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta Eventus BX a balloonexpandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries Eliac to treat aneurysmal iliac arteries and aneurysmal iliac side branches and Etegra an abdominal aortic aneurysms stent graft system In addition the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures PerClot an absorbable powdered hemostat for use in surgical procedures cardiac laser therapy products for angina treatment CryoVein femoral vein and CryoArtery femoral artery vascular preservation services OnX prosthetic aortic and mitral heart valves and the OnX ascending aortic prosthesis CarbonAid CO2 diffusion catheters and ChordX ePTFE sutures for mitral chordal replacement and ascyrus medical dissection stents as well as pyrolytic carbon coating services to medical device manufacturers It serves physicians hospitals and other healthcare facilities as well as cardiac vascular thoracic and general surgeons The company was formerly known as CryoLife Inc and changed its name to Artivion Inc in January 2022 The company was founded in 1984 and is headquartered in Kennesaw Georgia
Website: https://artivion.com
Rates and inflation backdrop
US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.15 and is up 0.0100 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.33. Cash flow to debt ratio: 0.13. Net profit margin: 2.21%. Inflation risk score: low (0.50/1).
Dividend history check
Yes, Artivion Inc pays dividends. Last payment was 2015-12-18 for holders on 2015-12-09. Over 14 payments between 2012 and 2015, total $0.397 with an average of $0.0284 per share. Last dividend was $0.0300.
Trading liquidity
Yes, the average daily trading liquidity for Artivion Inc is $16.8M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
On Artivion Inc, 2016-03-10 had a stock price of $10.81. If you invested back then, your return now would be a profit of $25.28 per share or 233.86%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.